DNA microarray to monitor the expression of MAGE-A genes

Clinical Chemistry

Volumn 48, Issue 1, 2002, Pages 25-34

  Zammatteo, N ^a   Lockman, L ^a   Brasseur, F ^a   De Plaen, E ^a   Lurquin, C ^a   Lobert, P E ^a   Hamels, S ^a   Boon, T ^a   Remacle, J ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; STREPTAVIDIN;

ANIMAL CELL; ARTICLE; DNA DETERMINATION; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAGE A GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

ANIMALIA;

EID: 0036137876     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.1.25     Document Type: Article

References (35)

1. T cell-defined tumor antigens
2. Structure, chromosomal localization and expression of twelve genes of the MAGE family
3. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis
4. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells
5. MAGE-B5, MAGE-B6, MAGE-C2 and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
6. Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins
7. Isolation and characterization of a new MAGE gene family in the Xp21.3 region
8. Identification of a new, unorthodox member of the MAGE gene family
9. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28
10. Cancer vaccines: Cancer antigens, shared tumor-specific antigens
11. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries
12. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
13. A MAGE-1 peptide recognized on HLA-DR15 by CD4+ T cells
14. Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
15. + cytolytic T lymphocytes
16. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis
17. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis
18. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
19. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes
20. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
21. Sequence and expression pattern of the human MAGE2 gene
22. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
23. Alternative promoters of gene MAGE4a
24. Guanidine isothiocyanate preparation of total RNA
25. Genes encoding tumor-specific antigens are expressed in human myeloma cells
26. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions
27. Colorimetric silver detection of DNA microarrays
28. High density synthetic oligonucleotide arrays
29. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes
30. Comparison between different strategies of covalent attachment of DNA to glass surfaces to build DNA microarrays
31. Detection of sickle cell β S-globin allele by hybridization with synthetic oligonucleotides
32. Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips
33. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays
34. Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids
35. DNA for simultaneous diagnosis of genus Staphylococcus, staphylococcal species and methicillin-resistance